Analyst Ratings for Day One Biopharmaceuticals (DAWN) [Sells]
DAWN Rating Summary
DAWN Price Target Summary
- Highest: $50.00 (H.C. Wainwright)
- Lowest: $9.00 (BofA Securities)
- Average: $35.57
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$35.57 (+132.3%)
* Over Last 12-Mos
Rating Score: 8.2 / 10
Percentile Rank: 85%
Avg. $ Target:
$35.57 (+132.3%)
* Over Last 12-Mos
Rating Score: 8.2 / 10
Percentile Rank: 85%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/25/2023 | BofA Securities | Alex Stranahan | Downgrade | Underperform (Buy) |
9.00 (34.00) |
13.71 (15.31) |
11.67% | Details |
